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Abstract
Background: Periodontitis is a chronic disease characterized by a progressive and irreversible destruction of the tooth-
supporting tissues, including gingiva and periodontal ligament (PDL). Microorganisms, such as Fusobacterium
nucleatum, evoke an inflammatory host response, which leads to increased levels of inflammatory mediators,
such as interleukin (IL)-1β. Periodontitis has been linked to obesity, and adipokines have been suggested to
represent a pathomechanistic link. The hormone somatostatin (SST) exerts antiproliferative, antiangiogenetic,
proapoptotic, anti-nociceptive and other effects through binding to its receptors, such as SSTR2. Therefore,
the objective of the present study was to examine the regulation of SSTR2 in periodontal cells and tissues
under inflammatory, microbial and obesity-related conditions.
Methods: In-vitro, human PDL fibroblasts were exposed to IL-1β, F. nucleatum, leptin or visfatin. The SSTR2
regulation was assessed by real-time PCR and immunocytochemistry. In-vivo, the SSTR2 expression was analyzed in
gingival biopsies of periodontally diseased and healthy subjects by real-time PCR and immunohistochemistry.
Additionally, the SSTR2 expression was determined in gingival biopsies of rats with ligature-induced periodontitis, rats
with diet-induced obesity, and periodontally and systemically healthy control animals. For statistical analyses, the Mann-
Whitney-U test and ANOVA with post-hoc tests were applied (p < 0.05).
Results: Exposure of PDL cells to IL-1β and F. nucleatum caused a significant SSTR2 upregulation by 2.6-fold and 6.4-fold,
respectively. Additionally, leptin and visfatin increased significantly the SSTR2 gene expression by 3.0-fold and
2.8-fold, respectively. These stimulatory effects were also observed at protein level. SSTR2 expressions in human gingival
biopsies from sites of periodontitis were significantly higher than those in healthy biopsies. Similarly, SSTR2
expression levels were significantly enhanced at periodontally-diseased sites in rat experimental periodontitis.
Finally, the SSTR2 expression was significantly upregulated in gingival biopsies of obese rats as compared to
normal weight control animals.
Conclusions: Our study provides original insights into the SSTR2 regulation in cells and tissues of the periodontium.
We demonstrate for the first time that proinflammatory, microbial and obesity-associated molecules result in an SSTR2
upregulation. Since SST has been shown to be antiproliferative, antiangiogenetic, and proapoptotic, our study suggests
that SSTR2 might play a critical role in the aetiopathogenesis of periodontitis.
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Background
Periodontitis is a highly prevalent chronic inflammatory
disease with social, psychological and physiological im-
pacts. The disease is characterized by progressive and
irreversible destruction of the tooth-supporting tissues,
i.e. the periodontium, which comprises the gingiva,
periodontal ligament (PDL), root cementum and alveo-
lar bone [1, 2]. Microorganisms of the subgingival bio-
film, such as Fusobacterium nucleatum, are essential
for the initiation and progression of periodontitis [3–5].
The periodontopathogenic microorganisms, their con-
stituents and products evoke an inflammatory host re-
sponse, which leads to increased levels of inflammatory
mediators, such as interleukin (IL)-1β, in gingival tis-
sues and crevicular fluid (GCF). The inflammatory pro-
cesses cause the release of matrix-degrading proteases
and osteoclast-activating factors, which can ultimately
result in attachment and tooth loss [3, 4, 6].
Periodontitis has been linked to a plethora of sys-
temic diseases and conditions, such as type II diabetes,
obesity and metabolic syndrome [7–10]. Although the
exact underlying mechanisms for the interactions
between periodontitis and these systemic diseases are
only partially known, it has been suggested that adipokines
might be a critical pathomechanistic link [11–13]. Obese
patients are characterized by an increased amount of adi-
pose tissue, which represents a complex endocrine and
highly active metabolic organ. In the adipose tissue, adipo-
cytes and other cells, such as leukocytes, secrete numer-
ous bioactive molecules, which are collectively called
adipokines [14–16]. Besides their function in the meta-
bolic regulation, adipokines also regulate inflammatory
and wound healing processes. Leptin and visfatin are
adipokines with proinflammatory characteristics. Since
the leptin secretion is proportional to the size and
number of adipocytes, the plasma leptin level is in-
creased in obese patients and decreased after weight
loss [17]. As for leptin, the plasma level of visfatin,
which is predominantly secreted by adipocytes and
macrophages, is also enhanced in obese individuals [18,
19]. These adipokines can also be measured in the gin-
gival tissues and GCF. Interestingly, their gingival levels
seem to be altered in the presence of periodontitis, sug-
gesting a local production and role of these adipokines
in periodontal diseases [20–25].
The polypeptide hormone somatostatin (SST) antago-
nizes growth hormone (GH) and exerts antiproliferative,
antiangiogenetic, proapoptotic, anti-nociceptive and other
effects [26, 27]. Although very little is known about the
presence and actions of SST in periodontal tissues, a few
studies have detected SST-producing dendritic cells in the
gingival epithelium and the subepithelial connective tissue
[28–30]. SST can bind to five ubiquitously distributed G
protein-coupled receptors (SSTR1–5), which mediate the
aforementioned effects of SST [26]. Activation of SSTR2,
which is one of the 5 receptors, results in a reduced ex-
pression of vascular endothelial growth factor (VEGF),
insulin-like growth factor (IGF)-1 and their receptors,
which all have been shown to be critical in periodontal
health and repair [31–34]. Furthermore, SSTR2 could be a
potential target for diagnostic strategies in periodontal
bone infection and inflammation [35]. Deciphering the
regulation of SSTR2 might be important for a better un-
derstanding of the aetiopathogenesis of periodontal dis-
eases. Therefore, the objective of the present study was to
examine the regulation of SSTR2 in periodontal cells and
tissues under inflammatory, microbial and obesity-related
conditions.
Material und methods
Culture and treatment of cells
PDL fibroblasts of caries-free and periodontal healthy
teeth extracted for orthodontic reasons were harvested
from 4 patients (mean age: 14.5 years, min-max: 11–19
years; gender: 3 male/1 female). Approval of the Ethics
Committee of the University of Bonn (#117/15) as well
as written and informed consent of the patients or legal
guardians were given. Cells were cultured as previously
described. Briefly, PDL tissue explants from the middle
third of the roots were grown in Dulbecco’s minimal
essential medium (DMEM, Invitrogen, Karlsruhe,
Germany) supplemented with 10% fetal bovine serum
(FBS, Invitrogen), 100 units penicillin and 100 μg/ml
streptomycin (PenStrep Invitrogen) at 37 °C in a hu-
midified atmosphere of 5% CO2 [36, 37]. For the exper-
iments, PDL fibroblasts of passages between 3 and 5
were used at 80% confluence. One day prior to the ex-
periments, the FBS concentration was reduced to 1%.
Physiological concentrations of IL-1β (0.1–10 ng/ml;
Calbiochem, San Diego, CA, USA), and F. nucleatum
(ATCC 25586; optical density at wave length of 660 nm:
0.0125–0.05), leptin (1–10 ng/ml; R&D Systems,
Minneapolis, MN, USA), and visfatin (30–300 ng/ml;
Biomol, Hamburg, Germany) were applied as in our
previous studies [21–23, 38–43]. F. nucleatum was
inactivated via suspension in PBS (optical density at
wave length of 660 nm = 1, equivalent to 1.2 × 109 bac-
terial cells/ml) and ultrasonication of 160W twice for
15 min. Inactivation of bacteria was checked by subcul-
tivation on Schaedler agar plates in anaerobic condi-
tions. PDL fibroblasts were exposed to the different
stimulants for 1 d. Untreated cells served as control.
Analysis of gene expression
The SSTR2 gene expression was analyzed via real-time
polymerase chain reaction (RT-PCR) by using an iCycler
iQ5 Detection System (Bio-Rad Laboratories, Munich,
Germany). Briefly, RNA was extracted with a RNA
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extraction kit (RNeasy Protect Mini Kit, Qiagen, Hil-
den, Germany) and transcribed to cDNA with the
iScript Select cDNA Synthesis Kit (Bio-Rad Laborator-
ies). Afterwards, a 25 μl reaction mixture was prepared,
containing 2.5 μl QuantiTect Primer Assay (Qiagen),
12.5 μl QuantiTect SYBR Green Master Mix (Qiagen)
and 9 μl of nuclease free water as well as 1 μl of cDNA.
The manufacturer’s protocol comprised a heating phase
at 95 °C for 5 min for enzyme activation as well as 40
cycles of a denaturation step at 95 °C for 10 s and a
combined annealing/extension step at 60 °C for 30 s.
Glyceraldehyde-3-phosphate dehydrogenase (GAPDH)
was used as an endogenous control.
Analysis of intracellular protein levels
PDL fibroblasts were cultured on glass coverslips in the
presence and absence of IL-1β, F. nucleatum, leptin or vis-
fatin (Carl Roth, Karlsruhe, Germany) for 24 h. Afterwards,
cells were fixed in 4% paraformaldehyde (Sigma-Aldrich,
Munich, Germany) at pH 7.4 and room temperature for 10
min, washed with PBS (Sigma-Aldrich), and treated with
0.1% Triton X-100 (Sigma-Aldrich) for 5 min. Background
staining was prevented by the application of serum block
for 20min (Dako, Hamburg Germany). After washing, cells
were incubated with a rabbit polyclonal anti-SSTR2 anti-
body (10 μg/ml; R&D Systems) at 4 °C overnight. Goat
anti-rabbit IgG-HRP (Dako) was applied as a secondary
antibody for 45 min. Antibody binding was visualized by
DAB chromogen (Thermo Fisher Scientific, Waltham, MA,
USA) staining for 10 min at room temperature. Two
washing steps with PBS (Sigma-Aldrich) were always per-
formed between the incubation steps. Finally, cells were
counterstained with Mayer’s Hematoxylin (Merck Eurolab,
Dietikon, Switzerland) for 1 min and coverslipped with
DePex mounting medium (Serva Electrophoresis, Heidel-
berg, Germany). Standardized photomicrographs were
taken with an Axioskop 2 microscope (Carl Zeiss, Jena,
Germany) equipped with an AxioCam MRc camera (Carl
Zeiss) and the AxioVision 4.7 software (Carl Zeiss).
Human biopsies
Gingival biopsies of 7 periodontally healthy donors
(mean age: 22.1 years, min–max: 18–26 years; gender: 2
male/5 female) and 7 periodontally-diseased patients
(mean age: 58.4 years, min–max: 29–81 years; gender: 5
male/2 female) were used for our experiments. These bi-
opsies were obtained during wisdom tooth extraction
and extractions for orthodontic or periodontal reasons
in the Department of Oral Surgery of the University of
Bonn [44]. Written and informed consent by the
subjects and approval by the Ethics Committee of the
University of Bonn (#043/11) were provided. Periodontal
health or disease were assessed by gingival index (GI),
probing pocket depth (PD), clinical attachment level
(CAL), and radiographic bone loss. No clinical inflam-
mation (GI = 0), a PD below 3mm and neither clinical
nor radiographic bone loss were categorized as peri-
odontally healthy. Periodontitis patients were identified
by sites with a GI > 1 and PD ≥ 5 mm and clinical as well
as radiographic bone loss ≥3 mm, as previously de-
scribed [21, 44, 45]. Smokers as well as patients taking
any medication were excluded from the study.
The gingival biopsies were harvested as described above
and then further analyzed by RT-PCR. In addition, the
SSTR2 protein levels of the biopsies were studied by im-
munohistochemistry. Briefly, the gingival tissues were
fixed with 4% paraformaldehyde (Sigma-Aldrich) for 2 d.
Subsequently, the tissues were hydrated, then dehydrated
in an ascending ethanol series (AppliChem, Darmstadt,
Germany) and, subsequently, embedded in paraffin
(McCormick Scientific, Richmond, IL, USA). Tissue slices
of 3 μm thickness were cut and mounted on glass slides
(Carl Roth). Finally, the slices were dried overnight, depar-
affinized, rehydrated, and rinsed in TBS (TRIS und NaCl,
MP Biomedicals, Illkirch, France; Merck KGaA, Darm-
stadt, Germany) for 10min. Endogenous peroxidase was
blocked with 0.3% methanol (AppliChem)/H2O2 (Merck
Eurolab) solution for 10min. Afterwards, an additional
blocking step with serum block (Dako) for 20min was car-
ried out. Finally, the sections were incubated with a rabbit
polyclonal anti-SSTR2 antibody (2.5 μg/ml; Research and
Diagnostic Systems) in a humid atmosphere at 4 °C over-
night. Goat anti-rabbit IgG-HRP (Dako) was used as a sec-
ondary antibody for 30 min, and the antibody binding was
visualized by DAB chromogen (Thermo Fisher Scientific).
Afterwards, the sections were counterstained with Mayer’s
Hematoxylin (Merck Eurolab), and then imaged with an
Axioskop 2 microscope (Carl Zeiss) equipped with an
AxioCam MRc camera (Carl Zeiss) and the AxioVision
4.7 software (Carl Zeiss), as described above.
Experimental periodontitis model
An experimental periodontits model was applied to
analyze the expression of SSTR2 in gingival biopsies dur-
ing the development of periodontal disease [46]. Thirty-
two male adult Holtzman rats (average weight: 300 g)
were assigned randomly to two experimental groups:
control (sham-operated) and experimental periodontitis.
Periodontitis was induced through cotton ligatures at
the cervical area of the upper first molars. The ligatures
were placed around the teeth, knotted mesially and left
there for up to 20 d. Protocol followed the ARRIVE
guidelines, and approval of the Ethical Committee on
Animal Experimentation (protocol number: 23/2012)
from the School of Dentistry at Araraquara, São Paulo
State University – UNESP, was obtained. Animal hous-
ing was provided at the animal facilities of the School of
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Dentistry at Araraquara under controlled conditions
(22–25 °C, 12 h light/dark cycle, standard laboratory diet
and water ad libitum). Ten % ketamine hydrochloride
(0.08 ml/100 g body weight) and 2% xylazine hydrochlor-
ide (0.04 ml/100 g body weight) were injected intramus-
cularly. Following 6 d, 8 d, 12 d, and 20 d, 4 animals per
group were sacrificed by an anesthetic overdose. The
maxillary jaws were harvested and, subsequently, the
gingival tissues around the maxillary first molars were
dissected for RNA extraction and RT-PCR (see above).
Diet-induced obesity model
Ten male Wistar rats purchased from Charles River
(Sulzfeld, Germany) were kept in a temperature (21 °C)
and humidity (35%) controlled environment with a 12-h
dark-light cycle. All animals received food and water ad
libitum. All procedures were conducted according to the
ethical standards of the University of Bonn (Az 87–
51.04.2010.A394). All applicable international, national,
and/or institutional guidelines for the care and use of
animals were followed. The rats were equally divided
into two groups. The animals of the test group were fed
a normal diet until week 4 and, subsequently, a high-fat
(25.1% fat), high sucrose (28.8% sucrose) diet (HFSD,
sniff, Germany) until week 15. The animals of the con-
trol group were provided a normal diet for the entire 15
weeks. Animal weight was determined and documented
weekly [47]. At week 15, the rats of the two groups were
sacrificed for further analyses. The jaws were harvested
and, subsequently, the gingival tissues were dissected for
RNA extraction and RT-PCR (see above).
Statistical analysis
Statistical analysis was carried out with the IBM SPSS
Statistics software (Version 22, IBM SPSS, Chicago, IL,
USA). Mean values and standard errors of the mean
(SEM) were calculated for quantitative data. Experi-
ments were done in triplicate and repeated at least twice.
For statistical comparisons, the t-test, Mann-Whitney-U
test or ANOVA followed by the post-hoc Dunnett’s test
were used. Differences between groups were considered
significant at p < 0.05.
Results
Regulation of SSTR2 gene expression by interleukin-1β, F.
nucleatum and adipokines
First, we sought to analyze whether proinflammatory,
microbial and obesity-related signals have an impact on
the expression of SSTR2 in PDL fibroblasts. Exposure
of cells to IL-1β caused a significant SSTR2 upregula-
tion by 2.6-fold, as shown in Fig. 1a. Further analysis
revealed that the stimulatory effect of IL-1β was
dose-dependent, with the highest dose resulting in the
most pronounced SSTR2 expression (Fig. 1b). In
addition, the periodontitis-associated microorganisms
F. nucleatum induced a significant increase in SSTR2
expression by 6.4-fold and this stimulatory action of F.
nucleatum was observed over a wide range of concen-
trations (Figs. 1a and c). Next we sought to examine
whether the SSTR2 expression is also regulated by the
proinflammatory adipokines leptin and visfatin. Inter-
estingly, leptin and visfatin induced a significant SSTR2
upregulation by 3.9-fold and 4.9-fold, respectively, as
shown in Fig. 1d. Further experiments demonstrated
that the stimulatory effects of the two adipokines de-
creased with increasing concentrations (Figs. 1e and f ).
Regulation of SSTR2 protein levels by interleukin-1β, F.
nucleatum and adipokines
We then analyzed by immunocytochemistry whether the
stimulatory actions of the proinflammatory, microbial
and obesity-related signals can also be observed at pro-
tein level. As depicted in Fig. 2, exposure of PDL fibro-
blast with IL-1β, F. nucleatum, leptin or visfatin resulted
in an enhanced immunoreactivity against SSTR2, as
compared with control cells. SSTR2 protein was found
to be equally distributed throughout the cell cytoplasm
(Fig. 2).
Regulation of SSTR2 in human and rat gingival biopsies
Finally, we sought to investigate whether the SSTR2 reg-
ulations, as observed in our in-vitro experiments, could
also be found in a more complex environment. There-
fore, human biopsies from periodontally-healthy and
periodontitis sites were obtained and, subsequently, ana-
lyzed for potential differences in the SSTR2 expression
and protein levels by RT-PCR and immunohistochemis-
try. As expected, the SSTR2 expression in gingival biop-
sies from sites of periodontitis was significantly higher
than that in healthy biopsies (Fig. 3a). In parallel, a
stronger immunoreaction to SSTR2 was found in in-
flamed biopsies as compared to the control tissues, but
control tissues also showed weak but continuous immu-
noreaction to SSTR2 as expected (Fig. 3b). Similarly,
SSTR2 expression levels were also significantly enhanced
at periodontally-diseased sites in a rat model of experi-
mental periodontitis. The time-course analysis revealed
that the SSTR2 expression increased in the presence of
plaque accumulation until day 12 and remained at this
significantly enhanced level until the end of the in-vivo
study (Fig. 3c). Lastly, we also studied the effects of
obesity on the SSTR2 expression in gingival biopsies in a
rat diet-induced obesity model. As analyzed by RT-PCR,
the SSTR2 expression was significantly upregulated in
gingival biopsies of obese rats as compared to normal-
weight control animals (Fig. 3d).
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Discussion
The present study provides novel insights into the
regulation of SSTR2 in periodontal cells and tissues.
Our in-vitro and in-vivo experiments show that proin-
flammatory, microbial and obesity-associated molecules
cause a strong upregulation of SSTR2. Since SST has
antiproliferative, antiangiogenetic, and proapoptotic ef-
fects, our findings suggest that SSTR2 might play a crit-
ical role in periodontal diseases.
There are only few studies, which have reported on
SST and its receptors in periodontal tissues [28–30].
However, the role of the SST/SSTR system in periodon-
tal health and disease has yet to be elucidated. We
therefore exposed periodontal fibroblasts to IL-1β,
which has been shown to be increased at periodontally
inflamed sites, and to the periodontopathogen F. nucle-
atum, which is a gram-negative anaerobic microorgan-
ism associated with gingivitis and periodontitis [5, 6].
Our experiments revealed that the SSTR2 expression
was enhanced under these inflammatory and microbial
conditions, indicating that the SST/SSTR system might
play an important role in periodontal inflammation and
infection. Interestingly, a study on human corneal epi-
thelial cells and an immortalized epithelial cell line
from human conjunctiva also demonstrated increased
SSTR2 expressions in response to proinflammatory cy-
tokines, such as IL-1ß, and bacterial components, such
as lipopolysaccharides or peptidoglycans [48]. These
Fig. 1 (a) SSTR2 expression in the presence or absence of IL-1β (1 ng/ml) or F. nucleatum (OD: 0.025) at 1 d. Untreated cells served as control. Mean ±
SEM (n = 6), * significantly (p < 0.05) different from control. (b) and (c) Effects of various concentrations of IL-1β (0.1–10 ng/ml) or F. nucleatum
(OD: 0.0125–0.05) on the SSTR2 expression at 1 d. Untreated cells served as control. Mean ± SEM (n = 6); * significantly (p < 0.05) different from
control. (d) SSTR2 expression in the presence or absence of leptin (3 ng/ml) or visfatin (100 ng/ml) at 1 d. Untreated cells served as control.
Mean ± SEM (n = 6), * significantly (p < 0.05) different from control. (e) and (f) Effects of various concentrations of leptin (1–10 ng/ml) or visfatin
(30–300 ng/ml) on the SSTR2 expression at 1 d. Untreated cells served as control. Mean ± SEM (n = 6); * significantly (p < 0.05) different from control
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findings concur well our data and emphasize the poten-
tial role of the SST/SSTR2 system in human physiology
and pathophysiology. Moreover, since periodontitis is
linked with obesity, we also incubated periodontal fi-
broblasts with the proinflammatory adipokines leptin
and visfatin, whose plasma levels are increased in obese
individuals [17, 19]. These adipokines are also produced
locally in periodontal tissues and altered at periodon-
tally inflamed sites, as studies by our group and other
investigators have shown [11, 21–23, 49]. Like IL-1β
and F. nucleatum, these adipokines also induced an up-
regulation of SSTR2, underlining their proinflammatory
characteristics and indicating a potential mechanism
whereby adipokines could contribute to periodontal de-
struction. To our best knowledge, our study is the first
one which links visfatin with SSTR2. The stimulatory
effects of IL-1β, F. nucleatum, leptin and visfatin on
SSTR2 were also observed at protein level, indicating
that our transcriptional findings are physiologically
relevant. In our experiments, the concentrations of the
stimulants were in the physiological range and consist-
ent with the doses of previous studies [44, 45, 49–51].
In order to validate our in-vitro findings in a more
complex environment, we also studied the SSTR2 ex-
pression in human biopsies from periodontally healthy
subjects and from periodontitis patients. As demon-
strated by RT-PCR and immunohistochemistry, SSTR2
levels were strongly enhanced at sites of periodontitis as
compared to control sites, thereby confirming the find-
ings of our in-vitro study, where IL-1β was used to
mimic periodontal inflammation and F. nucleatum was
applied to simulate periodontal infection. In a rat experi-
mental periodontitis model, we also investigated the
time course of SSTR2 expression in gingival biopsies. In
this model, ligatures were used to induce periodontitis,
which resulted in significant alveolar bone resorption, as
presented in our previous study [46]. The in-vivo study
supported our in-vitro data and the findings from the
human biopsies by demonstrating that microbial plaque
accumulation finally results in an upregulation of
SSTR2. Interestingly, a recent study focused on the ex-
pression of SSTRs in the jejunums of Cryptosporidium
parvum-infected rats [52]. The investigators found a
significant increase in the SSTR2 expression in the
Fig. 2 Effects of IL-1β (1 ng/ml), F. nucleatum (OD: 0.025), leptin (3 ng/ml) or visfatin (100 ng/ml) on SSTR2 protein levels in PDL fibroblasts at 1 d,
as analyzed by immunocytochemistry. Untreated cells served as control. Experiments were performed in triplicates and representative images of
cells from one donor are shown
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inflamed jejunum following infection, indicating that
SSTRs may regulate inflammatory pathways in rat intes-
tine. These findings are in accordance with our results
showing increased SSTR2 levels at inflamed sites. By
contrast, SSTR2 was found to be downregulated in a rat
lipopolysaccharide-induced periodontitis model [53].
However, in this model, periodontitis was caused by in-
jection of Escherichia coli lipopolysaccharides into the
palatal gingival sulci. In our model, periodontitis was
established through cotton ligatures at the cervical area
of the upper first molars, which usually results in the ac-
cumulation of a complex multispecies biofilm. We think
that this model better simulates the plaque-induced de-
velopment of periodontitis, as observed in humans, and
the differences in the applied models might explain the
opposite results. Moreover, our in-vivo findings are in
line with our in-vitro data, thereby supporting our in-
vivo observation. Taken together, our in-vitro and in-
vivo results suggest a potential role of SSTR2 in the
aetiopathogenesis of periodontitis.
Furthermore, we studied possible effects of obesity on
the SSTR2 expression in gingival biopsies in a rat
diet-induced obesity model [47]. This in-vivo study re-
vealed that obesity leads to an enhanced SSTR2 expres-
sion in gingival tissues, thereby supporting our in-vitro
experiments with adipokines. Interestingly, acute central
leptin infusion on the SSTR-effector system in the brain
of rats also resulted in increased SSTR2 gene and pro-
tein levels [54], indicating a regulatory role of leptin on
this receptor.
Although the present study suggests a potential role of
SSTR2 in the aetiopathogenesis of periodontal disease,
we have not examined the actions of SST itself and the
regulation of other SSTRs. Therefore, future studies
should also focus on the actions of SST and on the roles
of other SSTRs in periodontal cells and tissues. Add-
itionally, further studies should analyze the role of the
SST/SSTR system in different periodontal cells like gin-
gival fibroblasts.
In the present study, cells were exposed to the periodon-
topathogen F. nucleatum. However, periodontitis is a
chronic inflammatory disease caused by a highly complex
biofilm [5]. Therefore, further studies should also examine
the SSTR2 regulation by other microorganisms and their
combinations. In addition, like the microbial biofilm, the
inflammatory processes are also complex and involve a
plethora of pro- and antiinflammatory mediators [6].
Whether these molecules exert the same or opposite ef-
fects, as compared to IL-1β, has yet to be determined.
It has been suggested that adipokines, such as leptin
and visfatin, could represent a pathomechanistic link in
the interactions between periodontitis and obesity [11].
It is possible that adipokines contribute to the aetio-
pathogenesis of periodontitis, as a lot of studies suggest
Fig. 3 (a) SSTR2 expression in human gingival biopsies from periodontally inflamed and healthy sites. Mean ± SEM (n = 7 per group); * significant
(p < 0.05) difference between groups. (b) SSTR2 protein in human gingival biopsies from periodontally inflamed and healthy sites, as analyzed by
immunohistochemistry. Representative images of biopsies of one donor per group are shown. (c) SSTR2 expression in gingival biopsies of
rats with ligature-induce periodontitis at 6 d, 8 d, 12 d and 20 d, as compared to control animals. Mean ± SEM (n = 4/group and time);
* significantly (p < 0.05) different from control animals. (d) SSTR2 expression in gingival biopsies of obese and normal-weight rats. Mean ± SEM (n = 5);
* significant (p < 0.05) difference between groups
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[11–13]. However, adipokines are also produced locally
by periodontal cells and tissues [21–23]. Interestingly,
the local production of these adipokines is regulated by
inflammatory and microbial signals, suggesting that adi-
pokines also play a role in periodontal inflammation and
destruction in the absence of obesity. Future studies
should also examine the actions of other adipokines,
such as resistin or apelin, on the SST/SSTR2 system in
the periodontium. Moreover, further studies should be
dedicated to the intracellular signaling pathways, which
are involved in the observed SSTR2 upregulation.
Conclusions
Our study provides original insights into the SSTR2
regulation in cells and tissues of the periodontium. We
demonstrate for the first time that proinflammatory,
microbial and obesity-associated molecules result in an
SSTR2 upregulation. Since SST has been shown to be
antiproliferative, antiangiogenetic, and proapoptotic, our
study suggests that SSTR2 might play a critical role in
the aetiopathogenesis of periodontitis.
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